Literature DB >> 15788257

Regional brain abnormalities in 22q11.2 deletion syndrome: association with cognitive abilities and behavioral symptoms.

Carrie E Bearden1, Theo G M van Erp, John R Monterosso, Tony J Simon, David C Glahn, Peter A Saleh, Nicole M Hill, Donna M McDonald-McGinn, Elaine Zackai, Beverly S Emanuel, Tyrone D Cannon.   

Abstract

Children with 22q11.2 microdeletions (Velocardiofacial Syndrome; VCFS) have previously been shown to exhibit learning deficits and elevated rates of psychopathology. The aim of this study was to assess regional brain abnormalities in children with 22q11DS, and to determine the relationship of these measures to neurocognitive and behavioral function. Thirteen children with confirmed deletions and 9 demographically matched comparison subjects were assessed with a neurocognitive battery, behavioral measures, and high-resolution MRI. Twenty-two qllDS children showed a nonsignificant 4.3% global decrease in total brain volume as compared to healthy controls,with differential reduction in white matter, and significantly increased sulcal cerebrospinal fluid (CSF) in temporal and posterior brain regions. In 22q11 DS subjects, but not controls, bilateral temporal gray and white matter volumes were significant predictors of overall cognitive performance. Further, reduced temporal gray matter was associated with elevated Thought Problems score on the CBCL. Results indicate that global alterations in brain volume are common in children with 22q deletions, particularly those with low IQ and/or behavioral disturbance. Although preliminary,these findings suggest a possible underlying pathophysiology of the cognitive deficits seen in this syndrome,and provide insight into complex gene-brain-behavior relationships.

Entities:  

Mesh:

Year:  2004        PMID: 15788257     DOI: 10.1080/13554790490495519

Source DB:  PubMed          Journal:  Neurocase        ISSN: 1355-4794            Impact factor:   0.881


  17 in total

1.  Clinical and genetic high-risk paradigms: converging paths to psychosis meet in the temporal lobes.

Authors:  Maria Jalbrzikowski; Carrie E Bearden
Journal:  Biol Psychiatry       Date:  2011-05-15       Impact factor: 13.382

Review 2.  Cortical mapping of genotype-phenotype relationships in schizophrenia.

Authors:  Carrie E Bearden; Theo G M van Erp; Paul M Thompson; Arthur W Toga; Tyrone D Cannon
Journal:  Hum Brain Mapp       Date:  2007-06       Impact factor: 5.038

Review 3.  Neural phenotypes of common and rare genetic variants.

Authors:  Carrie E Bearden; David C Glahn; Agatha D Lee; Ming-Chang Chiang; Theo G M van Erp; Tyrone D Cannon; Allan L Reiss; Arthur W Toga; Paul M Thompson
Journal:  Biol Psychol       Date:  2008-02-23       Impact factor: 3.251

Review 4.  Comprehensive neurocognitive endophenotyping strategies for mouse models of genetic disorders.

Authors:  Michael R Hunsaker
Journal:  Prog Neurobiol       Date:  2012-01-13       Impact factor: 11.685

5.  Attentional functioning in individuals with 22q11 deletion syndrome: insight from ERPs.

Authors:  Daniela Mannarelli; Caterina Pauletti; Tommaso Accinni; Luca Carlone; Marianna Frascarelli; Guido Maria Lattanzi; Antonio Currà; Francesco Fattapposta
Journal:  J Neural Transm (Vienna)       Date:  2018-03-08       Impact factor: 3.575

6.  Mapping cortical thickness in children with 22q11.2 deletions.

Authors:  Carrie E Bearden; Theo G M van Erp; Rebecca A Dutton; Helen Tran; Lara Zimmermann; Daqiang Sun; Jennifer A Geaga; Tony J Simon; David C Glahn; Tyrone D Cannon; Beverly S Emanuel; Arthur W Toga; Paul M Thompson
Journal:  Cereb Cortex       Date:  2006-10-20       Impact factor: 5.357

7.  Association of schizophrenia in 22q11.2 deletion syndrome and gray matter volumetric deficits in the superior temporal gyrus.

Authors:  Eva W C Chow; Andrew Ho; Corie Wei; Eduard H J Voormolen; Adrian P Crawley; Anne S Bassett
Journal:  Am J Psychiatry       Date:  2011-03-01       Impact factor: 18.112

Review 8.  Converging levels of analysis on a genomic hotspot for psychosis: insights from 22q11.2 deletion syndrome.

Authors:  Matthew J Schreiner; Maria T Lazaro; Maria Jalbrzikowski; Carrie E Bearden
Journal:  Neuropharmacology       Date:  2012-10-23       Impact factor: 5.250

9.  Evidence of gray matter reduction and dysfunction in chromosome 22q11.2 deletion syndrome.

Authors:  Vandana Shashi; Thomas R Kwapil; Jessica Kaczorowski; Margaret N Berry; Cesar S Santos; Timothy D Howard; Dhruman Goradia; Konasale Prasad; Diwadkar Vaibhav; Rajaprabhakaran Rajarethinam; Edward Spence; Matcheri S Keshavan
Journal:  Psychiatry Res       Date:  2010-01-30       Impact factor: 3.222

Review 10.  Velocardiofacial syndrome: is there a neuropsychiatric phenotype?

Authors:  Edith M Jolin; Elizabeth B Weller; Ronald A Weller
Journal:  Curr Psychiatry Rep       Date:  2006-04       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.